Key regions: United States, South Korea, Japan, Canada, India
The Digestive & Intestinal Remedies (Pharmacies) market in Iran has been experiencing steady growth in recent years. Customer preferences for natural and herbal remedies, coupled with increasing awareness about digestive health, have been driving this growth. Additionally, local special circumstances and underlying macroeconomic factors have also played a role in shaping the market trends. Customer preferences in Iran have shifted towards natural and herbal remedies for digestive and intestinal issues. This can be attributed to a growing interest in alternative medicine and a desire for more holistic approaches to healthcare. Consumers are increasingly seeking out products that are made from natural ingredients and have minimal side effects. As a result, there has been a rise in the demand for herbal supplements and traditional remedies that are believed to promote digestive health. Trends in the market also reflect the increasing awareness about digestive health in Iran. With changing lifestyles and dietary habits, digestive issues such as indigestion, bloating, and acid reflux have become common problems. This has led to a greater demand for over-the-counter remedies that provide relief from these symptoms. Pharmacies in Iran have responded to this demand by expanding their range of digestive and intestinal remedies, offering a variety of options to cater to different needs. Local special circumstances in Iran have also influenced the development of the Digestive & Intestinal Remedies market. The country has a rich tradition of herbal medicine, with many traditional remedies being passed down through generations. This has created a strong cultural belief in the efficacy of natural remedies for digestive health. As a result, there is a preference for locally-made products that incorporate traditional ingredients and manufacturing techniques. Furthermore, underlying macroeconomic factors have contributed to the growth of the market. Iran has experienced economic growth in recent years, leading to an increase in disposable income. This has allowed consumers to spend more on healthcare products, including digestive and intestinal remedies. Additionally, the expanding middle class in Iran has also contributed to the growing demand for these products, as they prioritize their health and well-being. In conclusion, the Digestive & Intestinal Remedies market in Iran is developing due to customer preferences for natural and herbal remedies, increasing awareness about digestive health, local special circumstances, and underlying macroeconomic factors. As consumers continue to prioritize their digestive health and seek out alternative remedies, the market is expected to continue its growth trajectory in the coming years.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
